$BMRN
BIOMARIN PHARMACEUTICAL INC

2012 Q4 Form 10-Q Financial Statement

#000119312512439875 Filed on October 29, 2012

View on sec.gov

Income Statement

Concept 2012 Q4 2012 Q3 2011 Q4
Revenue $131.9M $128.1M $107.8M
YoY Change 22.36% 12.95% 6.1%
Cost Of Revenue $26.50M $24.62M $21.50M
YoY Change 23.26% 9.69% 4.88%
Gross Profit $105.4M $103.5M $86.30M
YoY Change 22.13% 13.76% 6.41%
Gross Profit Margin 79.91% 80.78% 80.06%
Selling, General & Admin $55.00M $46.34M $48.50M
YoY Change 13.4% 3.25% 15.2%
% of Gross Profit 52.18% 44.77% 56.2%
Research & Development $84.40M $66.21M $57.90M
YoY Change 45.77% 13.03% 37.2%
% of Gross Profit 80.08% 63.97% 67.09%
Depreciation & Amortization $10.90M $8.900M $9.600M
YoY Change 13.54% 9.88% 21.52%
% of Gross Profit 10.34% 8.6% 11.12%
Operating Expenses $139.4M $112.5M $106.4M
YoY Change 31.02% 8.79% 26.22%
Operating Profit -$34.00M -$10.49M -$20.10M
YoY Change 69.15% -32.39% 528.13%
Interest Expense -$14.30M $1.837M -$3.300M
YoY Change 333.33% -15.27% 43.48%
% of Operating Profit
Other Income/Expense, Net -$1.800M $100.0K $200.0K
YoY Change -1000.0% -133.33%
Pretax Income -$50.10M -$11.76M -$23.10M
YoY Change 116.88% -40.39% 20.31%
Income Tax $2.900M -$6.404M $3.600M
% Of Pretax Income
Net Earnings -$53.00M -$5.357M -$26.70M
YoY Change 98.5% -69.65% 118.85%
Net Earnings / Revenue -40.18% -4.18% -24.77%
Basic Earnings Per Share
Diluted Earnings Per Share -$425.4K -$43.76K -$231.6K
COMMON SHARES
Basic Shares Outstanding 123.8M shares 123.6M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2012 Q4 2012 Q3 2011 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $447.8M $426.5M $195.1M
YoY Change 129.52% 90.06% -28.82%
Cash & Equivalents $180.5M $181.3M $46.27M
Short-Term Investments $267.3M $245.1M $148.8M
Other Short-Term Assets $25.51M $54.82M $18.64M
YoY Change 36.87% 67.63% -44.98%
Inventory $128.7M $120.8M $130.1M
Prepaid Expenses $11.42M $7.551M
Receivables $109.1M $117.3M $104.8M
Other Receivables $0.00 $9.000M $0.00
Total Short-Term Assets $743.4M $719.4M $469.8M
YoY Change 58.24% 47.72% -6.83%
LONG-TERM ASSETS
Property, Plant & Equipment $284.5M $273.7M $269.0M
YoY Change 5.76% 2.83% 21.23%
Goodwill $51.54M $51.54M $51.54M
YoY Change 0.0% -3.41%
Intangibles $163.0M $165.6M $180.3M
YoY Change -9.59% 73.93%
Long-Term Investments $117.1M $107.6M $94.90M
YoY Change 23.39% -26.7% -26.6%
Other Assets $19.54M $19.74M $15.50M
YoY Change 26.13% -91.87% 9.0%
Total Long-Term Assets $824.9M $848.0M $835.9M
YoY Change -1.31% 4.94% 10.23%
TOTAL ASSETS
Total Short-Term Assets $743.4M $719.4M $469.8M
Total Long-Term Assets $824.9M $848.0M $835.9M
Total Assets $1.568B $1.567B $1.306B
YoY Change 20.11% 21.02% 3.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.99M $11.46M $12.24M
YoY Change 96.04% 61.39% 144.78%
Accrued Expenses $43.16M $36.39M $23.85M
YoY Change 80.96% -43.5% -64.88%
Deferred Revenue
YoY Change
Short-Term Debt $23.40M $23.40M $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $170.4M $134.9M $94.13M
YoY Change 81.07% 61.98% 12.26%
LONG-TERM LIABILITIES
Long-Term Debt $324.9M $324.9M $348.3M
YoY Change -6.72% -6.72% -7.74%
Other Long-Term Liabilities $26.67M $92.39M $19.99M
YoY Change 33.42% 76.32% -76.2%
Total Long-Term Liabilities $26.67M $92.39M $19.99M
YoY Change 33.42% -76.94% -76.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $170.4M $134.9M $94.13M
Total Long-Term Liabilities $26.67M $92.39M $19.99M
Total Liabilities $552.6M $552.2M $532.7M
YoY Change 3.74% 6.09% -2.33%
SHAREHOLDERS EQUITY
Retained Earnings -$539.4M -$486.4M -$425.1M
YoY Change 26.9% 14.5%
Common Stock $1.562B $1.506B $1.197B
YoY Change 30.47% 9.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.016B $1.015B $773.0M
YoY Change
Total Liabilities & Shareholders Equity $1.568B $1.567B $1.306B
YoY Change 20.11% 21.02% 3.41%

Cashflow Statement

Concept 2012 Q4 2012 Q3 2011 Q4
OPERATING ACTIVITIES
Net Income -$53.00M -$5.357M -$26.70M
YoY Change 98.5% -69.65% 118.85%
Depreciation, Depletion And Amortization $10.90M $8.900M $9.600M
YoY Change 13.54% 9.88% 21.52%
Cash From Operating Activities $12.00M $14.20M -$100.0K
YoY Change -12100.0% 61.36% -99.37%
INVESTING ACTIVITIES
Capital Expenditures -$13.90M -$15.00M -$89.70M
YoY Change -84.5% -73.36% 730.56%
Acquisitions
YoY Change
Other Investing Activities -$38.50M -$5.900M $54.80M
YoY Change -170.26% 210.53% -1989.66%
Cash From Investing Activities -$52.30M -$21.00M -$35.00M
YoY Change 49.43% -63.98% 157.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 39.60M 10.30M 10.10M
YoY Change 292.08% 32.05% -200.0%
NET CHANGE
Cash From Operating Activities 12.00M 14.20M -100.0K
Cash From Investing Activities -52.30M -21.00M -35.00M
Cash From Financing Activities 39.60M 10.30M 10.10M
Net Change In Cash -700.0K 3.500M -25.00M
YoY Change -97.2% -108.39% -36.71%
FREE CASH FLOW
Cash From Operating Activities $12.00M $14.20M -$100.0K
Capital Expenditures -$13.90M -$15.00M -$89.70M
Free Cash Flow $25.90M $29.20M $89.60M
YoY Change -71.09% -55.15% -1892.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
71254000
CY2012Q3 us-gaap Goodwill
Goodwill
51543000
CY2012Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
34811000
CY2012Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
143773000
CY2012Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
4444000
CY2012Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
414337000
CY2012Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
23951000
CY2012Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1505776000
CY2012Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
4012000
CY2012Q3 us-gaap Other Assets Current
OtherAssetsCurrent
54816000
CY2012Q3 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
9018000
CY2012Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
19739000
CY2012Q3 us-gaap Business Acquisition Contingent Consideration At Fair Value
BusinessAcquisitionContingentConsiderationAtFairValue
35290000
CY2012Q3 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
744000
CY2012Q3 us-gaap Foreign Currency Derivative Assets At Fair Value
ForeignCurrencyDerivativeAssetsAtFairValue
3632000
CY2012Q3 us-gaap Stockholders Equity
StockholdersEquity
1015194000
CY2012Q3 us-gaap Business Acquisition Contingent Consideration At Fair Value Current
BusinessAcquisitionContingentConsiderationAtFairValueCurrent
5921000
CY2012Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
76659000
CY2012Q3 us-gaap Availableforsale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses2
AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses2
19000
CY2012Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
54898000
CY2012Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7873000
CY2012Q3 us-gaap Available For Sale Securities Gross Unrealized Gain Loss
AvailableForSaleSecuritiesGrossUnrealizedGainLoss
448000
CY2012Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2012Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
21935000
CY2012Q3 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
4272000
CY2012Q3 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
3114000
CY2012Q3 us-gaap Availableforsale Securities Continuous Unrealized Loss Position Aggregate Losses2
AvailableforsaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses2
110000
CY2012Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
123790150 shares
CY2012Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
67718000
CY2012Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
56235000
CY2012Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
53154000
CY2012Q3 us-gaap Common Stock Issued Employee Stock Trust
CommonStockIssuedEmployeeStockTrust
6603000
CY2012Q3 us-gaap Liabilities
Liabilities
552182000
CY2012Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
11459000
CY2012Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11415000
CY2012Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
92392000
CY2012Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
5165000
CY2012Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
53241000
CY2012Q3 us-gaap Long Term Investments
LongTermInvestments
106741000
CY2012Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1476000
CY2012Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
181330000
CY2012Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
229771000
CY2012Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-486436000
CY2012Q3 us-gaap Assets
Assets
1567376000
CY2012Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
7891000
CY2012Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
32698000
CY2012Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
324861000
CY2012Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
117290000
CY2012Q3 us-gaap Inventory Net
InventoryNet
120825000
CY2012Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
546831000
CY2012Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1567376000
CY2012Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
65362000
CY2012Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
8956000
CY2012Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
23440000
CY2012Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
21424000
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
181330000
CY2012Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
118242000
CY2012Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
123790150 shares
CY2012Q3 us-gaap Foreign Currency Derivative Liabilities At Fair Value
ForeignCurrencyDerivativeLiabilitiesAtFairValue
791000
CY2012Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
165624000
CY2012Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
3406000
CY2012Q3 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
1384000
CY2012Q3 us-gaap Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
351418000
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2333000
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1015000 shares
CY2012Q3 us-gaap Business Acquisition Contingent Consideration At Fair Value Noncurrent
BusinessAcquisitionContingentConsiderationAtFairValueNoncurrent
29369000
CY2012Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
36385000
CY2012Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
111489000
CY2012Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
13768000
CY2012Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
10578000
CY2012Q3 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
900000
CY2012Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
1084000
CY2012Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
13134000
CY2012Q3 us-gaap Liabilities Current
LiabilitiesCurrent
134929000
CY2012Q3 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
3544000
CY2012Q3 us-gaap Restricted Investments At Fair Value
RestrictedInvestmentsAtFairValue
5731000
CY2012Q3 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
2132000
CY2012Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
63689000
CY2012Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
341000
CY2012Q3 us-gaap Availableforsale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses2
AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses2
91000
CY2012Q3 us-gaap Short Term Investments
ShortTermInvestments
245125000
CY2012Q3 us-gaap Common Stock Value
CommonStockValue
124000
CY2012Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
7720000
CY2012Q3 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
13667000
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q3 us-gaap Interest Payable Current
InterestPayableCurrent
2681000
CY2012Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16307000
CY2012Q3 us-gaap Land
Land
10056000
CY2012Q3 us-gaap Assets Current
AssetsCurrent
719386000
CY2012Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
39339000
CY2012Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
140613000
CY2012Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
273724000
CY2012Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
848000
CY2012Q3 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
351866000
CY2012Q3 bmrn Computer Hardware And Software
ComputerHardwareAndSoftware
53011000
CY2012Q3 bmrn Deferred Compensation Liability Included In Other Long Term Liabilities
DeferredCompensationLiabilityIncludedInOtherLongTermLiabilities
0.96 pure
CY2012Q3 bmrn Contingent Acquisition Consideration Payable Included In Accounts Payable And Accrued Liabilities
ContingentAcquisitionConsiderationPayableIncludedInAccountsPayableAndAccruedLiabilities
0.17 pure
CY2012Q3 bmrn Contingent Acquisition Consideration Payable Included In Other Long Term Liabilities
ContingentAcquisitionConsiderationPayableIncludedInOtherLongTermLiabilities
0.83 pure
CY2012Q3 bmrn Percentage Of Deferred Compensation Asset Included In Other Assets
PercentageOfDeferredCompensationAssetIncludedInOtherAssets
0.98 pure
CY2012Q3 bmrn Available For Sale Securities Debt Maturities Within Four Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinFourYearsAmortizedCost
45889000
CY2012Q3 bmrn Available For Sale Securities Debt Maturities Within Three Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinThreeYearsAmortizedCost
41426000
CY2012Q3 bmrn Available For Sale Securities Debt Maturities Within Two Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinTwoYearsAmortizedCost
210862000
CY2012Q3 bmrn Gross Intangible Assets
GrossIntangibleAssets
181931000
CY2012Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
123826066 shares
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88079000
CY2011Q4 us-gaap Goodwill
Goodwill
51543000
CY2011Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
41803000
CY2011Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
141484000
CY2011Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
5866000
CY2011Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
384716000
CY2011Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
21115000
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1197082000
CY2011Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
0
CY2011Q4 us-gaap Other Assets Current
OtherAssetsCurrent
39753000
CY2011Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
6093000
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15495000
CY2011Q4 us-gaap Business Acquisition Contingent Consideration At Fair Value
BusinessAcquisitionContingentConsiderationAtFairValue
38614000
CY2011Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
289000
CY2011Q4 us-gaap Foreign Currency Derivative Assets At Fair Value
ForeignCurrencyDerivativeAssetsAtFairValue
6682000
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
773048000
CY2011Q4 us-gaap Business Acquisition Contingent Consideration At Fair Value Current
BusinessAcquisitionContingentConsiderationAtFairValueCurrent
5555000
CY2011Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
72039000
CY2011Q4 us-gaap Availableforsale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses2
AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses2
196000
CY2011Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
55436000
CY2011Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9259000
CY2011Q4 us-gaap Available For Sale Securities Gross Unrealized Gain Loss
AvailableForSaleSecuritiesGrossUnrealizedGainLoss
70000
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2011Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
17619000
CY2011Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
3505000
CY2011Q4 us-gaap Availableforsale Securities Continuous Unrealized Loss Position Aggregate Losses2
AvailableforsaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses2
231000
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
114789732 shares
CY2011Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
75903000
CY2011Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
70744000
CY2011Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
51275000
CY2011Q4 us-gaap Common Stock Issued Employee Stock Trust
CommonStockIssuedEmployeeStockTrust
3935000
CY2011Q4 us-gaap Liabilities
Liabilities
530633000
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12239000
CY2011Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7551000
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
88179000
CY2011Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
5165000
CY2011Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
148872000
CY2011Q4 us-gaap Long Term Investments
LongTermInvestments
94385000
CY2011Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
3165000
CY2011Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
46272000
CY2011Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
222649000
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-425101000
CY2011Q4 us-gaap Assets
Assets
1303681000
CY2011Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
6530000
CY2011Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
35127000
CY2011Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
348329000
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
104839000
CY2011Q4 us-gaap Inventory Net
InventoryNet
130118000
CY2011Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
299664000
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1303681000
CY2011Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
49456000
CY2011Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
6025000
CY2011Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
0
CY2011Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
28941000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46272000
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2011Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
118242000
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
114789732 shares
CY2011Q4 us-gaap Foreign Currency Derivative Liabilities At Fair Value
ForeignCurrencyDerivativeLiabilitiesAtFairValue
220000
CY2011Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
180277000
CY2011Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
2991000
CY2011Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
2376000
CY2011Q4 us-gaap Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
243135000
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4887000
CY2011Q4 us-gaap Business Acquisition Contingent Consideration At Fair Value Noncurrent
BusinessAcquisitionContingentConsiderationAtFairValueNoncurrent
33059000
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23849000
CY2011Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
94125000
CY2011Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
12145000
CY2011Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
7679000
CY2011Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
2119000
CY2011Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
342000
CY2011Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
8768000
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
94125000
CY2011Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
4705000
CY2011Q4 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
0
CY2011Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
70396000
CY2011Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
513000
CY2011Q4 us-gaap Availableforsale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses2
AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses2
35000
CY2011Q4 us-gaap Short Term Investments
ShortTermInvestments
148820000
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
115000
CY2011Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
950000
CY2011Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
9450000
CY2011Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1300000
CY2011Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8361000
CY2011Q4 us-gaap Land
Land
10056000
CY2011Q4 us-gaap Assets Current
AssetsCurrent
469802000
CY2011Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
42070000
CY2011Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
115745000
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
268971000
CY2011Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
559000
CY2011Q4 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
243205000
CY2011Q4 bmrn Computer Hardware And Software
ComputerHardwareAndSoftware
48566000
CY2011Q4 bmrn Deferred Compensation Liability Included In Other Long Term Liabilities
DeferredCompensationLiabilityIncludedInOtherLongTermLiabilities
0.93 pure
CY2011Q4 bmrn Contingent Acquisition Consideration Payable Included In Accounts Payable And Accrued Liabilities
ContingentAcquisitionConsiderationPayableIncludedInAccountsPayableAndAccruedLiabilities
0.14 pure
CY2011Q4 bmrn Contingent Acquisition Consideration Payable Included In Other Long Term Liabilities
ContingentAcquisitionConsiderationPayableIncludedInOtherLongTermLiabilities
0.86 pure
CY2011Q4 bmrn Percentage Of Deferred Compensation Asset Included In Other Assets
PercentageOfDeferredCompensationAssetIncludedInOtherAssets
0.96 pure
CY2011Q4 bmrn Available For Sale Securities Debt Maturities Within Three Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinThreeYearsAmortizedCost
3100000
CY2011Q4 bmrn Available For Sale Securities Debt Maturities Within Two Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinTwoYearsAmortizedCost
91163000
CY2011Q4 bmrn Gross Intangible Assets
GrossIntangibleAssets
188638000
us-gaap Costs And Expenses
CostsAndExpenses
345967000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1019000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
215298000
us-gaap Operating Income Loss
OperatingIncomeLoss
-12455000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
331583000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
us-gaap Contracts Revenue
ContractsRevenue
375000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25985000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
23436000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
1903000
us-gaap Share Based Compensation
ShareBasedCompensation
32721000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1459000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
6147000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
us-gaap Increase Decrease In Asset Retirement Obligations
IncreaseDecreaseInAssetRetirementObligations
0
us-gaap Depreciation And Amortization
DepreciationAndAmortization
26466000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
18928000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-54646000
us-gaap Investment Income Interest
InvestmentIncomeInterest
2302000
us-gaap Income Taxes Paid
IncomeTaxesPaid
3386000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-114000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
64539000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-16825000
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
us-gaap Other Payments To Acquire Businesses
OtherPaymentsToAcquireBusinesses
1894000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
2234000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20481000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-20511000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
156466000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18893000
us-gaap Cost Of Revenue
CostOfRevenue
62504000
us-gaap Royalty Revenue
RoyaltyRevenue
1554000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
109000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-5699000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5930000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1817000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
227094000
us-gaap Revenues
Revenues
333512000
us-gaap Depreciation
Depreciation
22800000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
32607000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-110000
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
1896000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
524000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-3055000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
111358000 shares
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
6844000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
35532000 shares
us-gaap Net Income Loss
NetIncomeLoss
-27101000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
109000
us-gaap Interest Paid Net
InterestPaidNet
4019000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
126969000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6590000
us-gaap Interest Expense
InterestExpense
6531000
us-gaap Debt Instrument Convertible Interest Expense
DebtInstrumentConvertibleInterestExpense
5500000
bmrn Stockbased Compensation Capitalized
StockbasedCompensationCapitalized
3978000
bmrn Supplemental Accrued Expenses
SupplementalAccruedExpenses
2373000
bmrn Change Of Business Acquisition Contingent Consideration At Fair Value
ChangeOfBusinessAcquisitionContingentConsiderationAtFairValue
2390000
bmrn Sales Revenue Goods Net Percentages
SalesRevenueGoodsNetPercentages
1.00 pure
bmrn Percentage Of Net Product Revenue Attributed To Largest Customers
PercentageOfNetProductRevenueAttributedToLargestCustomers
0.47 pure
bmrn Intangible Asset Amortization And Contingent Consideration
IntangibleAssetAmortizationAndContingentConsideration
-28000
bmrn Depreciation Expense Capitalized Into Inventory
DepreciationExpenseCapitalizedIntoInventory
4067000
dei Trading Symbol
TradingSymbol
BMRN
dei Entity Registrant Name
EntityRegistrantName
BIOMARIN PHARMACEUTICAL INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2012-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0001048477
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Costs And Expenses
CostsAndExpenses
432096000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Reclassifications</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Certain items in the Company&#x2019;s prior year Condensed Consolidated Financial Statements have been reclassified to conform to the current presentation.</font></p> </div>
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
8625000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
276817000
us-gaap Operating Income Loss
OperatingIncomeLoss
-63311000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
365540000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
235499000
us-gaap Contracts Revenue
ContractsRevenue
1729000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-63889000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
37667000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
1258000
us-gaap Share Based Compensation
ShareBasedCompensation
35414000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
15825000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
8154000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.52
us-gaap Increase Decrease In Asset Retirement Obligations
IncreaseDecreaseInAssetRetirementObligations
415000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
33438000
us-gaap Derivative Instruments Loss Recognized In Other Comprehensive Income Effective Portion
DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion
3300000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5623000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-143292000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1819000
us-gaap Income Taxes Paid
IncomeTaxesPaid
5591000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax
3500000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-15000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30676000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
135058000
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>(3) RECENT ACCOUNTING PRONOUNCEMENTS</b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In July 2012, the Financial Accounting Standards Board issued Accounting Standards Update No.&#xA0;2012-02, <i>Intangibles&#x2014;Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment (ASU 2012-02)</i>. This ASU states than an entity has the option to first assess qualitative factors to determine whether the existence of events and circumstances indicates that it is &#x201C;more likely than not&#x201D; that an indefinite-lived intangible asset, other than goodwill, is impaired. The results of the qualitative assessment will determine whether it is necessary to perform the quantitative impairment test described in Topic 350. ASU 2012-02 is effective for annual and interim impairment tests performed for fiscal years beginning after September&#xA0;15, 2012, which for the Company means January&#xA0;1, 2013. Early adoption is permitted, including for annual and interim impairment tests performed as of a date before July&#xA0;27, 2012, if an entity's financial statements for the most recent annual or interim period have not yet been issued. Because the measurement of a potential impairment has not changed, the adoption of ASU 2012-02 will not have a material impact on the Company&#x2019;s financial position or results of operations.</font></p> </div>
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
6707000
us-gaap Other Payments To Acquire Businesses
OtherPaymentsToAcquireBusinesses
0
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12451000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-68184000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
217855000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
272727000
us-gaap Cost Of Revenue
CostOfRevenue
65298000
us-gaap Royalty Revenue
RoyaltyRevenue
1516000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
96000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
4846000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-9293000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-968000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
165459000
us-gaap Revenues
Revenues
368785000
us-gaap Depreciation
Depreciation
25700000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
3300000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
35907000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
6905000
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
0
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
535000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-3075000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
118810000 shares
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-10610000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
35111000 shares
us-gaap Net Income Loss
NetIncomeLoss
-61335000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
96000
us-gaap Interest Paid Net
InterestPaidNet
3597000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
143124000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2200000 shares
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6849000
CY2012Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
6700000
CY2011Q3 us-gaap Costs And Expenses
CostsAndExpenses
128942000
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-15517000
us-gaap Interest Expense
InterestExpense
5709000
us-gaap Debt Instrument Convertible Interest Expense
DebtInstrumentConvertibleInterestExpense
5000000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
37.35
bmrn Stockbased Compensation Capitalized
StockbasedCompensationCapitalized
3042000
bmrn Supplemental Accrued Expenses
SupplementalAccruedExpenses
1488000
bmrn Change Of Business Acquisition Contingent Consideration At Fair Value
ChangeOfBusinessAcquisitionContingentConsiderationAtFairValue
3325000
bmrn Sales Revenue Goods Net Percentages
SalesRevenueGoodsNetPercentages
1.00 pure
bmrn Percentage Of Product Revenue Exceeding Consolidated Net Product Revenue
PercentageOfProductRevenueExceedingConsolidatedNetProductRevenue
0.10 pure
bmrn Percentage Of Net Product Revenue Attributed To Largest Customers
PercentageOfNetProductRevenueAttributedToLargestCustomers
0.42 pure
bmrn Contingent Payments Upon Achievement Of Certain Regulatory And Licensing Milestones
ContingentPaymentsUponAchievementOfCertainRegulatoryAndLicensingMilestones
357600000
bmrn Intangible Asset Amortization And Contingent Consideration
IntangibleAssetAmortizationAndContingentConsideration
-5819000
bmrn Depreciation Expense Capitalized Into Inventory
DepreciationExpenseCapitalizedIntoInventory
4744000
CY2012Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
235500000
CY2012Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
6500000 shares
CY2012Q2 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
36.28
CY2011 us-gaap Derivative Instruments Loss Recognized In Other Comprehensive Income Effective Portion
DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion
8000000
CY2011 bmrn Number Of Customers Accounted For Largest Balance In Account Receivable
NumberOfCustomersAccountedForLargestBalanceInAccountReceivable
2 pure
CY2011Q3 us-gaap Debt Instrument Convertible Interest Expense
DebtInstrumentConvertibleInterestExpense
1800000
CY2011Q3 bmrn Sales Revenue Goods Net Percentages
SalesRevenueGoodsNetPercentages
1.00 pure
CY2011Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
112891000
CY2011Q3 us-gaap Contracts Revenue
ContractsRevenue
97000
CY2011Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10426000
CY2011Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
CY2011Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2011Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
722000
CY2011Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-264000
CY2011Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-19731000
CY2011Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
58577000
CY2011Q3 us-gaap Cost Of Revenue
CostOfRevenue
22445000
CY2011Q3 us-gaap Royalty Revenue
RoyaltyRevenue
437000
CY2011Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-608000
CY2011Q3 us-gaap Revenues
Revenues
113425000
CY2011Q3 us-gaap Depreciation
Depreciation
8100000
CY2011Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11618000
CY2011Q3 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
1896000
CY2011Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
112290000 shares
CY2011Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
35578000 shares
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
-17653000
CY2011Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
44880000
CY2011Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2078000
CY2011Q3 us-gaap Interest Expense
InterestExpense
2168000
CY2011Q3 bmrn Percentage Of Net Product Revenue Attributed To Largest Customers
PercentageOfNetProductRevenueAttributedToLargestCustomers
0.50 pure
CY2011Q3 bmrn Intangible Asset Amortization And Contingent Consideration
IntangibleAssetAmortizationAndContingentConsideration
-3040000
CY2011Q3 bmrn Depreciation Expense Capitalized Into Inventory
DepreciationExpenseCapitalizedIntoInventory
2100000
CY2012Q3 us-gaap Costs And Expenses
CostsAndExpenses
138608000
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10491000
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
126310000
CY2012Q3 us-gaap Contracts Revenue
ContractsRevenue
1210000
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7674000
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2012Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
778000
CY2012Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
125000
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11761000
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
66209000
CY2012Q3 us-gaap Cost Of Revenue
CostOfRevenue
24619000
CY2012Q3 us-gaap Royalty Revenue
RoyaltyRevenue
597000
CY2012Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-336000
CY2012Q3 us-gaap Revenues
Revenues
128117000
CY2012Q3 us-gaap Depreciation
Depreciation
8900000
CY2012Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
600000
CY2012Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12139000
CY2012Q3 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
0
CY2012Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
123434000 shares
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
35161000 shares
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-5357000
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
46337000
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6404000
CY2012Q3 us-gaap Interest Expense
InterestExpense
1837000
CY2012Q3 us-gaap Debt Instrument Convertible Interest Expense
DebtInstrumentConvertibleInterestExpense
1700000
CY2012Q3 bmrn Number Of Customers Accounted For Largest Balance In Account Receivable
NumberOfCustomersAccountedForLargestBalanceInAccountReceivable
2 pure
CY2012Q3 bmrn Sales Revenue Goods Net Percentages
SalesRevenueGoodsNetPercentages
1.00 pure
CY2012Q3 bmrn Percentage Of Net Product Revenue Attributed To Largest Customers
PercentageOfNetProductRevenueAttributedToLargestCustomers
0.43 pure
CY2012Q3 bmrn Intangible Asset Amortization And Contingent Consideration
IntangibleAssetAmortizationAndContingentConsideration
-1443000
CY2012Q3 bmrn Depreciation Expense Capitalized Into Inventory
DepreciationExpenseCapitalizedIntoInventory
2500000

Files In Submission

Name View Source Status
0001193125-12-439875-index-headers.html Edgar Link pending
0001193125-12-439875-index.html Edgar Link pending
0001193125-12-439875.txt Edgar Link pending
0001193125-12-439875-xbrl.zip Edgar Link pending
bmrn-20120930.xml Edgar Link completed
bmrn-20120930.xsd Edgar Link pending
bmrn-20120930_cal.xml Edgar Link unprocessable
bmrn-20120930_def.xml Edgar Link unprocessable
bmrn-20120930_lab.xml Edgar Link unprocessable
bmrn-20120930_pre.xml Edgar Link unprocessable
d416526d10q.htm Edgar Link pending
d416526dex311.htm Edgar Link pending
d416526dex312.htm Edgar Link pending
d416526dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending